MedFire Media launches a 10-part masterclass teaching board-certified plastic surgeons AI-powered patient acquisition strategies using its OmniDominance™ AMP content system, addressing how AI tools now shape patient research and surgeon visibility.

Waterlooville, United Kingdom, October 30, 2026 -- MedFire Media has launched a 10-part masterclass teaching board-certified plastic surgeons how to acquire patients through AI-powered marketing, built around the company's proprietary OmniDominance™ AMP system. The launch responds to a shift in how prospective patients now find and vet surgeons before ever picking up the phone.

More information is available at https://www.medfiremedia.com/free-course

Tools such as ChatGPT and Google's AI Overview increasingly shape which practices get seen during a patient's early research, ahead of any traditional website visit or search-engine click. Traditional marketing tactics, built around static websites and occasional advertising, no longer guarantee a surgeon appears when these systems answer patient questions, and practices absent from that AI-driven layer risk going unseen at the exact moment patients form their first impressions.

Industry reporting indicates that patients considering procedures such as rhinoplasty often research for eight to eighteen months before booking a consultation. MedFire Media describes this as the CREDibility Pathway, spanning Curiosity, Research, Evaluation and Decision, and argues that surgeons who focus only on the final decision stage miss most of that process. Content marketing that reaches patients earlier, the company says, can build trust well before a consultation is scheduled.

The masterclass walks surgeons through AI patient acquisition strategies built on the OmniDominance™ AMP system, which the company explains turns a single piece of expert content into eight formats: news articles, blog posts, short-form videos, long-form videos, podcast interviews, infographics, flipbook eBooks and social posts. These formats are then distributed across hundreds of high-authority platforms without paid advertising, positioning surgeons as authorities across procedure-specific topics.

The company reports internal metrics showing the OmniDominance™ AMP system generating fourteen times more AI citations and six times more organic traffic compared with single-tier content distribution. A case study cited by the company describes a plastic surgery practice filling its consultation calendar within 67 days of adopting the system, without increasing advertising spend. These figures form part of the rationale behind the masterclass content.

Board-certified plastic surgeons are invited to enroll in the masterclass as part of MedFire Media's wider mission: helping practices achieve predictable patient flow and long-term growth through a fully managed content marketing system that requires no paid ads. The company positions the course as a practical entry point for surgeons seeking visibility across both search engines and AI research tools.

Further details on MedFire Media and its OmniDominance™ AMP system are available at https://medfiremedia.com

Contact Info:
Name: Paul Briley
Email: Send Email
Organization: MedFire Media
Address: 101 Woodsedge, Waterlooville, Hampshire PO7 8PX, United Kingdom
Website: https://medfiremedia.com

Source: NewsNetwork

Release ID: 89207970

If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.